Skip to content

Effect of esketamine on perioperative anxiety and depression and postoperative quality of recovery after gynecological cancer surgery

Low-dose esmketamine improves perioperative anxiety and depression in elderly patients with gynecological cancer surgery and its related mechanism

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099920
Enrollment
Unknown
Registered
2025-04-01
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative depression

Interventions

Exposed group (Application of esmketamine):NA
Non-exposed group (Not using esmketamine):NA

Sponsors

Women’s Hospital of Nanjing Medical University, Nanjing Women and Children’s Healthcare Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. ASA grade I-II; 2. Aged 60-80 years old; 3. Body mass index = 35 kg/m^2; 4. Elective gynecological cancer surgery.

Exclusion criteria

Exclusion criteria: 1. Patients with severe cardiovascular disease, hyperthyroidism or risk of increased intracranial pressure; 2. Previous psychiatric diseases (such as Parkinson's disease, depression, anxiety, etc.); 3. History of psychotropic drug, opioid drug or alcohol dependence; 4. Contraindications to general anesthesia or patients refusing general anesthesia; 5. Patients with known ingredients of the study drug or allergy to other drugs used in the study.

Design outcomes

Primary

MeasureTime frame
Hospital Anxiety and Depression Scale (HADS);VAS pain scores;

Secondary

MeasureTime frame
15-item quality of recovery scale (QoR15);Confusion Assessment Method for the Intensive Care Unit (CAM-ICU );NRS, AIS;Total intraoperative consumption of opioid sufentanil;Use of rescue analgesics;PONV;adverse events (Respiratory depression, dizziness and mental side effects);severe complications (Pulmonary complications, cardiac complications, central nervous system complications, gastrointestinal complications, sepsis, postoperative bleeding, reoperation, death);Postoperative hospitalization days;

Countries

China

Contacts

Public ContactWen Yazhou

Women’s Hospital of Nanjing Medical University, Nanjing Women and Children’s Healthcare Hospital

wenasia@163.com+86 136 0145 9819

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026